Stock analysts at Cantor Fitzgerald increased their FY2024 EPS estimates for Exagen in a research note issued to investors on Monday, March 10th. Cantor Fitzgerald analyst R. Osborn now forecasts that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results